Nuchal Translucency Evaluation at 11 to 14 Weeks Gestational Age
暂无分享,去创建一个
Msb | mdj | K. Maturen | V. Feldstein | L. Pōder | E. Oliver | Loretta M. Strachowski | B. Sussman | T. Weber | P. Glanc | C. Zelop | L. Simpson | Md. | Betsy L. Sussman | MD h Phyllis Glanc | MD a Lynn Simpson | MD MS b Katherine E. Maturen | MD c Vickie A. Feldstein | M. E. R. Edward R. Oliver | MD e Liina Poder | MD f Loretta M. Strachowski | MD g Betsy L. Sussman | MD Therese M. Weber | M. M. T. Tom Winter | MD j Carolyn M. Zelop | Lynn Simpson | Md | MSb | Edward R. Oliver | Therese M. Weber | MDj
[1] M. Kilby,et al. Early prognostic factors of outcomes in monochorionic twin pregnancy: systematic review and meta‐analysis , 2018, American journal of obstetrics and gynecology.
[2] M. Shohat,et al. Cut‐off value of nuchal translucency as indication for chromosomal microarray analysis , 2017, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[3] M. Norton,et al. Testing for Noonan syndrome after increased nuchal translucency , 2017, Prenatal diagnosis.
[4] S. Ferrero,et al. Fetal Tricuspid Regurgitation in the First Trimester as a Screening Marker for Congenital Heart Defects: Systematic Review and Meta-Analysis , 2017, Fetal Diagnosis and Therapy.
[5] R. Quintero,et al. Early prediction of twin‐to‐twin transfusion syndrome: systematic review and meta‐analysis , 2017, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[6] M. Melchior,et al. Screening for fetal congenital heart disease , 2017, Canadian Medical Association Journal.
[7] J. Neilson,et al. First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening. , 2017, The Cochrane database of systematic reviews.
[8] S. Blackwell,et al. The role of ultrasound in women who undergo cell‐free DNA screening , 2017, American journal of obstetrics and gynecology.
[9] L. Simpson. Practice Bulletin No. 175: Ultrasound in Pregnancy , 2016, Obstetrics and gynecology.
[10] E. Hayes. Practice Bulletin No. 169: Multifetal Gestations Twin, Triplet, and Higher-Order Multifetal Pregnancies , 2016, Obstetrics and gynecology.
[11] Practice Bulletin No. 162 Summary: Prenatal Diagnostic Testing for Genetic Disorders , 2016, Obstetrics and gynecology.
[12] Practice Bulletin No. 163 Summary: Screening for Fetal Aneuploidy , 2016, Obstetrics and gynecology.
[13] Qiao-ling Feng,et al. Fetal echocardiography for congenital heart disease diagnosis: a meta-analysis, power analysis and missing data analysis , 2015, European journal of preventive cardiology.
[14] Y. Blumenfeld,et al. Genomic microarray in fetuses with increased nuchal translucency and normal karyotype: a systematic review and meta‐analysis , 2015, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[15] T. van Mieghem,et al. Early fetal anatomy screening: who, what, when and why? , 2015, Current opinion in obstetrics & gynecology.
[16] M. D'Alton,et al. Nuchal Translucency Quality Review (NTQR) program: first one and half million results , 2015, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[17] C. Bilardo,et al. Early detection of fetal cardiac abnormalities: how effective is it and how should we manage these patients? , 2014, Prenatal diagnosis.
[18] C. Comas,et al. Systematic review of screening for trisomy 21 in twin pregnancies in first trimester combining nuchal translucency and biochemical markers: a meta‐analysis , 2014, Prenatal diagnosis.
[19] H. Cuckle,et al. Nuchal translucency in twins according to mode of assisted conception and chorionicity , 2014, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[20] F. Prefumo,et al. Accuracy of Ultrasonography at 11–14 Weeks of Gestation for Detection of Fetal Structural Anomalies: A Systematic Review , 2013, Obstetrics and gynecology.
[21] L. Simpson. Ultrasound in twins: dichorionic and monochorionic. , 2013, Seminars in perinatology.
[22] K. Nicolaides,et al. Fetal heart defects: potential and pitfalls of first-trimester detection. , 2013, Seminars in fetal & neonatal medicine.
[23] E. Kanal,et al. ACR guidance document on MR safe practices: 2013 , 2013, Journal of magnetic resonance imaging : JMRI.
[24] K. Nicolaides,et al. Contribution of Fetal Tricuspid Regurgitation in First-Trimester Screening for Major Cardiac Defects , 2011, Obstetrics and gynecology.
[25] Kypros H Nicolaides,et al. Screening for fetal aneuploidies at 11 to 13 weeks , 2011, Prenatal diagnosis.
[26] K. Nicolaides,et al. Challenges in the diagnosis of fetal non‐chromosomal abnormalities at 11–13 weeks , 2011, Prenatal diagnosis.
[27] Rvt,et al. AIUM Practice Guideline for the Performance of Fetal Echocardiography , 2011, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[28] K. Nicolaides,et al. Additional first-trimester ultrasound markers. , 2010, Clinics in laboratory medicine.
[29] K. Nicolaides,et al. Ductus Venosus in the First Trimester: Contribution to Screening of Chromosomal, Cardiac Defects and Monochorionic Twin Complications , 2010, Fetal Diagnosis and Therapy.
[30] N. Montenegro,et al. Screening for twin–twin transfusion syndrome at 11–14 weeks of pregnancy: the key role of ductus venosus blood flow assessment , 2010, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[31] E. Gratacós,et al. Prevalence and perinatal outcome of dichorionic and monochorionic twins with nuchal translucency above the 99th percentile and normal karyotype , 2010, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[32] K. Kagan,et al. Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11–13 weeks of gestation , 2009, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[33] I. Staboulidou,et al. Ductus Venosus Doppler at 11 to 13 Weeks of Gestation in the Prediction of Outcome in Twin Pregnancies , 2009, Obstetrics and gynecology.
[34] K. Kagan,et al. Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11–13 weeks of gestation , 2009, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[35] F. Malone,et al. Maintaining quality assurance for sonographic nuchal translucency measurement: lessons from the FASTER Trial , 2009, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[36] I. Timor-Tritsch,et al. Performing a Fetal Anatomy Scan at the Time of First-Trimester Screening , 2009, Obstetrics and gynecology.
[37] K. Kagan,et al. Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11 + 0 to 13 + 6 weeks of gestation , 2009, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[38] P. Lewi,et al. The role of ultrasound examination in the first trimester and at 16 weeks' gestation to predict fetal complications in monochorionic diamniotic twin pregnancies. , 2008, American journal of obstetrics and gynecology.
[39] T. Crombleholme,et al. Initial fetal cardiovascular profile score predicts recipient twin outcome in twin-twin transfusion syndrome. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[40] K. Kagan,et al. Frontomaxillary facial angle in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks , 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[41] K. Nicolaides,et al. Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency thickness , 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[42] A. Rebarber,et al. First-trimester screening with nasal bone in twins. , 2007, American journal of obstetrics and gynecology.
[43] J. Hyett,et al. Nuchal translucency and the risk of congenital heart disease. , 2007, Obstetrics and gynecology.
[44] K. Kagan,et al. Discordance in nuchal translucency thickness in the prediction of severe twin‐to‐twin transfusion syndrome , 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[45] F. Malone,et al. Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening? , 2006, American journal of obstetrics and gynecology.
[46] R. Berkowitz,et al. First trimester screening for Down syndrome in multiple pregnancy. , 2005, Seminars in perinatology.
[47] A. Rudnicka,et al. First-trimester or second-trimester screening, or both, for Down's syndrome. , 2005, The New England journal of medicine.
[48] F. Malone,et al. First-Trimester Septated Cystic Hygroma: Prevalence, Natural History, and Pediatric Outcome , 2005, Obstetrics and gynecology.
[49] K. Nicolaides,et al. Screening for trisomy 21 in monochorionic twins by measurement of fetal nuchal translucency thickness , 2005, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[50] I. Blickstein,et al. Down syndrome screening in multiple pregnancies. , 2005, Obstetrics and gynecology clinics of North America.
[51] J. Ioannidis,et al. Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis. , 2003, American journal of obstetrics and gynecology.
[52] F. Malone,et al. First‐Trimester Sonographic Screening for Down Syndrome , 2003, Obstetrics and gynecology.
[53] R. Quintero,et al. Twin-twin transfusion syndrome. , 2003, Clinics in perinatology.
[54] W. Giles,et al. The Doppler Assessment in multiple pregnancy randomised controlled trial of ultrasound biometry versus umbilical artery Doppler ultrasound and biometry in twin pregnancy , 2003, BJOG : an international journal of obstetrics and gynaecology.
[55] K. Nicolaides,et al. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one‐stop clinic: a review of three years experience , 2003, BJOG : an international journal of obstetrics and gynaecology.
[56] M. Haak,et al. Echocardiography in Early Pregnancy , 2003, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[57] S. Cicero,et al. Increased fetal nuchal translucency at 11–14 weeks , 2002, Prenatal diagnosis.
[58] S. Cicero,et al. Fetal nasal bone length in chromosomally normal and abnormal fetuses at 11–14 weeks of gestation , 2002, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[59] K. Hecher,et al. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome , 2001, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[60] K. Nicolaides,et al. Early prediction of severe twin-to-twin transfusion syndrome. , 2000, Human reproduction.
[61] K. Nicolaides,et al. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation , 1998, The Lancet.
[62] K. Nicolaides,et al. Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10–14 weeks of gestation , 1996, British journal of obstetrics and gynaecology.
[63] D. Economides,et al. The measurement of nuchal translucency with transabdominal and transvaginal sonography--success rates, repeatability and levels of agreement. , 1995, The British journal of radiology.
[64] K. Nicolaides,et al. First‐Trimester Fetal Nuchal Translucency Thickness and Risk for Trisomies , 1994, Obstetrics and gynecology.
[65] K. Nicolaides,et al. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. , 1992, BMJ.
[66] I. Thaler,et al. FIRST TRIMESTER TRANSVAGINAL SONOGRAPHIC DIAGNOSIS OF FETAL ANOMALIES , 1989, The Lancet.
[67] PARAMETER FOR IMAGING PREGNANT OR POTENTIALLY PREGNANT ADOLESCENTS AND WOMEN WITH IONIZING RADIATION , 2016 .
[68] F. Mri. ACR-SPR PRACTICE PARAMETER FOR THE SAFE AND OPTIMAL PERFORMANCE OF FETAL MAGNETIC RESONANCE IMAGING (MRI) , 2014 .
[69] F. Walther,et al. Congenital heart disease in twin-to-twin transfusion syndrome treated with fetoscopic laser surgery. , 2007, Congenital heart disease.
[70] A. Nadel. First-trimester nasal bone evaluation for aneuploidy in the general population. , 2005, Obstetrics and gynecology.
[71] S. Cox,et al. Society for Maternal-Fetal Medicine , 1999 .
[72] K. Nicolaides,et al. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency , 1995, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.